SlideShare a Scribd company logo
By – SARVESH MAURYA 
DR.L.H.HIRANANDANI 
COLLEGE OF PHARMACY.
 MOLECULAR ARCHITECTURE OF ION 
CHANNELS 
• Ion channels are large and elaborate molecules. All 
consist of several (often four) domains, which are 
similar or identical to each other, organised either as an 
oligomeric array of separate subunits, or as one large 
protein. 
• Each subunit or domain contains a bundle of two to six 
membrane-spanning helices. Most ligand-gated 
channels have the basic structure, comprising a 
pentameric array of non-identical subunits, each 
consisting of four transmembrane helices. 
•The large extracellular N-terminal region contains the 
ligand-binding region
Types Of Na+ Channels 
•Voltage gated – 
Changes in membrane 
polarity open the 
channel
•Ligand gated (nicotinic 
acetylcholine receptor) – Ligand 
binding alters channel/receptor 
conformation and opens the 
pore 
•Mechanically gated (stretch receptor) – 
Physical torsion or deformation opens the 
channel pore
Voltage-gated sodium channels: 
Introduction 
• Voltage-gated sodium channels are responsible for action potential initiation and 
propagation in excitable cells, including nerve, muscle, and neuroendocrine cell types. 
• They are also expressed at low levels in nonexcitable cells, where their physiological role is 
unclear. Sodium channels are the founding members of the ion channel superfamily in terms 
of their discovery as a protein and determination of their amino acid sequence. 
Sodium Channel Subunits 
• Sodium channels consist of a highly processed α subunit, which is approximately 260 kDa, 
associated with auxiliary β subunits Sodium channels in the adult central nervous system and 
heart contain β1 through β4 subunits, whereas sodium channels in adult skeletal muscle have 
only the β1 subunit . 
• The pore-forming α subunit is sufficient for functional expression, but the kinetics and 
voltage dependence of channel gating are modified by the β subunits, and these auxiliary 
subunits are involved in channel localization and interaction with cell adhesion molecules, 
extracellular matrix, and intracellular cytoskeleton.
•The α subunits are organized in four homologous domains (I-IV), each of which contain six 
transmembrane α helices (S1-S6) and an additional pore loop located between the S5 and 
S6 segments (Fig. 1). The pore loops line the outer, narrow entry to the pore, whereas the 
S5 and S6 segments line the inner, wider exit from the pore. The S4 segments in each 
domain contain positively charged amino acid residues at every third position. 
•These residues serve as gating charges and move across the membrane to initiate channel 
activation in response to depolarization of the membrane. The short intracellular loop 
connecting homologous domains III and IV serves as the inactivation gate, folding into the 
channel structure and blocking the pore from the inside during sustained depolarization of 
the membrane. 
FIG. 1. Transmembrane organization of sodium channel subunits.
•The primary structures of the subunits of the voltage-gated ion channels are illustrated as 
transmembrane-folding diagrams. Cylinders represent probable α-helical segments. Bold lines 
represent the polypeptide chains of each subunit, with length approximately proportional to the 
number of amino acid residues in the brain sodium channel subtypes. 
•The extracellular domains of the β1 and β2 subunits are shown as immunoglobulin-like folds. 
ψ, sites of probable N-linked glycosylation; P, sites of demonstrated protein phosphorylation by 
protein kinase A (circles) and protein kinase C (diamonds); shaded, pore-lining S5-P-S6 
segments; white circles, the outer (EEDD) and inner (DEKA) rings of amino residues that form 
the ion selectivity filter and tetrodotoxin binding site; ++, S4 voltage sensors; h in shaded 
circle, inactivation particle in the inactivation gate loop; open shaded circles, sites implicated in 
forming the inactivation gate receptor. 
•Sites of binding of α- and β-scorpion toxins and a site of interaction between α and β1 
subunits are also shown.
Sodium Channel Classification and Nomenclature 
 In this nomenclature system, the name of an individual channel consists of the chemical 
symbol of the principal permeating ion (Na) with the principal physiological regulator (voltage) 
indicated as a subscript (NaV). 
 The number following the subscript indicates the gene subfamily (currently only NaV1), and 
the number following the full point identifies the specific channel isoform (e.g., NaV1.1). This 
last number has been assigned according to the approximate order in which each gene was 
identified. Splice variants of each family member are identified by lowercase letters following 
the numbers (e.g., NaV1.1a).
Genetic mutations in sodium channel genes give rise to channelopathies and 
clinical disease 
Channel 
nomenclature 
Gene 
Chromosomal 
location 
(human) 
Tetrodotoxin 
sensitivity 
Major tissue 
expression 
Effect of 
mutation 
Nav1.1 SCN1A 2q24 CNS, PNS Epilepsy 
Nav1.2 SCN2A 2q23–24 CNS, PNS Epilepsy 
Nav1.3 SCN3A 2q24 CNS, PNS None reported 
Nav1.4 SCN4A 17q23–25 Skeletal muscle 
Myotonia, 
periodic 
paralysis 
Nav1.5 SCN5A 3p21 Heart 
Long QT, 
Brugada 
syndrome, 
progressive 
familial heart 
block 
Nav1.6 SCN8A 12q13 CNS, PNS 
Cerebellar 
atrophy 
Nav1.7 SCN9A 2q24 
PNS (SNS and 
PAs) 
Increased and 
decreased pain 
sensitivity 
Voltage-gated sodium channel nomenclature, chromosomal location and tissue distribution
Sodium Channels - Function 
Can be in different functional states (3) 
A resting 
state 
• when it can respond to a depolarizing voltage 
changes 
Activated 
• when it allows flow of Na+ ions through the 
Inactivated 
• when subjected to a “suprathreshold” 
potential, the channel will not open
Na + Channel Blockers/Pharmacological Agents 
• Tetrodotoxin (TTX)(blocks voltage gated sodium 
channel) 
• Amioderone (blocks cardiac channel) 
• Lidocaine (blocks voltage sodium channel in neuronal 
cell membrane) 
• Procainamide 
• Mexilitine 
• Ketamine
Tetrodoxin 
•Tetrodotoxin is the poison that is produced by the puffer fish and a number of other animals. It 
is a virulent poison, the LD50 for the mouse is 10 nanograms. 
• It acts by blocking the conduction of nerve impulses along nerve fibers and axons. The victim 
eventually dies from respiratory paralysis. 
Saxitoxin, a natural product 
from dinoflagellates, acts in a similar way and 
is also a potent nerve poison."
If tetrodotoxin is such a powerful toxin why does 
it not poison the host? 
This is a common question in virtually all cases where a toxin is 
present. 
The sodium ion channel in the host must be different than that 
of the victim. 
It must not be susceptible to the toxin.
It has been demonstrated for one of the pufferfish that the protein of 
the sodium ion channel has undergone a mutation that changes the 
amino acid sequence making the channel insensitive to tetrodotoxin. 
The spontaneous mutation that caused this structural change is 
beneficial to the pufferfish because it allowed it to incorporate the 
symbiotic bacteria and utilize the toxin it produces to its best advantage, 
A single point mutation in the amino acid sequence of the sodium-ion 
channel in this species renders it immune from being bound and 
blockaded by TTX.
Side effects occur while taking Amiodarone 
Dizziness 
Cough 
trembling or shaking of the hands 
lightheadedness, or 
fainting, Dizziness 
Common 
side 
efects 
unusual and 
uncontrolled 
movements of 
the body 
shortnes 
s of 
breath 
Cough, 
fever 
(slight) 
numbness or 
tingling in the 
fingers or toes
Blue-gray coloring of 
the skin on the face, 
neck, and arms 
Less common 
side effects 
blurred vision or blue-green 
halos seen around 
objects 
fast or irregular 
heartbeat 
dry, puffy skin 
dry eyes
•REFERENCES 
•William A. Catterall, Alan L. Goldin, Stephen G. Waxman. 
Voltage-gated sodium channels, introductory chapter. 
•Adapted from the original article 
in Pharmacological Reviews
Na channel

More Related Content

What's hot (20)

Mapk modified
Mapk modifiedMapk modified
Mapk modified
WIPRO BPS
 
Ion channels
Ion channelsIon channels
Ion channels
HARINATHA REDDY ASWARTHAGARI
 
Ion channels as drug target
Ion channels as drug targetIon channels as drug target
Ion channels as drug target
Dr Ranjita Santra(Dhali)
 
Ion channels
Ion channelsIon channels
Ion channels
Bahauddin zakariya university,Multan
 
4 signal ligand gated ion channels.
4 signal ligand gated ion channels.4 signal ligand gated ion channels.
4 signal ligand gated ion channels.
Arunachalam Muthuraman
 
Voltage Gated Calcium Channels (VGCC) and Its Role in Neurological Diseases
Voltage Gated Calcium Channels (VGCC) and Its Role in Neurological DiseasesVoltage Gated Calcium Channels (VGCC) and Its Role in Neurological Diseases
Voltage Gated Calcium Channels (VGCC) and Its Role in Neurological Diseases
Ade Wijaya
 
Animal models of nociception (pain)
Animal models of nociception (pain)Animal models of nociception (pain)
Animal models of nociception (pain)
ankit
 
Drug receptors in pharmacology
Drug receptors in pharmacologyDrug receptors in pharmacology
Drug receptors in pharmacology
Bindu Pulugurtha
 
Enzyme linked receptor
Enzyme linked receptorEnzyme linked receptor
Enzyme linked receptor
shakshisharma20
 
Histamine as a cns neurotransmitter
Histamine as a cns neurotransmitterHistamine as a cns neurotransmitter
Histamine as a cns neurotransmitter
Mohd Uzair Ansari
 
G- Protein Coupled Receptors
G- Protein Coupled ReceptorsG- Protein Coupled Receptors
G- Protein Coupled Receptors
Dr. Prashant Shukla
 
Zinc finger protein
Zinc finger proteinZinc finger protein
Zinc finger protein
yogeeta Goyat
 
Jak stat pathway
Jak stat pathwayJak stat pathway
Jak stat pathway
MugdhaSharma11
 
Classification of receptors family by vivek sharma
Classification of receptors family by vivek sharmaClassification of receptors family by vivek sharma
Classification of receptors family by vivek sharma
AnimatedWorld
 
Nuclear Receptors
Nuclear ReceptorsNuclear Receptors
Nuclear Receptors
Arslan Tahir
 
Patch clamp technique
Patch clamp techniquePatch clamp technique
Patch clamp technique
Hovsep Ghazaryan
 
Screening of anti-emetic drugs
Screening of anti-emetic drugsScreening of anti-emetic drugs
Screening of anti-emetic drugs
Dr. Prashant Shukla
 
Potassium (K+) channels
Potassium (K+) channelsPotassium (K+) channels
Potassium (K+) channels
Jaineel Dharod
 
Slideshare second messengers aj
Slideshare second messengers ajSlideshare second messengers aj
Slideshare second messengers aj
Anu Priya
 
Genome organization and gene expression and its regulation
Genome organization and gene expression and its regulationGenome organization and gene expression and its regulation
Genome organization and gene expression and its regulation
abhishek soni
 
Mapk modified
Mapk modifiedMapk modified
Mapk modified
WIPRO BPS
 
Voltage Gated Calcium Channels (VGCC) and Its Role in Neurological Diseases
Voltage Gated Calcium Channels (VGCC) and Its Role in Neurological DiseasesVoltage Gated Calcium Channels (VGCC) and Its Role in Neurological Diseases
Voltage Gated Calcium Channels (VGCC) and Its Role in Neurological Diseases
Ade Wijaya
 
Animal models of nociception (pain)
Animal models of nociception (pain)Animal models of nociception (pain)
Animal models of nociception (pain)
ankit
 
Drug receptors in pharmacology
Drug receptors in pharmacologyDrug receptors in pharmacology
Drug receptors in pharmacology
Bindu Pulugurtha
 
Histamine as a cns neurotransmitter
Histamine as a cns neurotransmitterHistamine as a cns neurotransmitter
Histamine as a cns neurotransmitter
Mohd Uzair Ansari
 
Classification of receptors family by vivek sharma
Classification of receptors family by vivek sharmaClassification of receptors family by vivek sharma
Classification of receptors family by vivek sharma
AnimatedWorld
 
Potassium (K+) channels
Potassium (K+) channelsPotassium (K+) channels
Potassium (K+) channels
Jaineel Dharod
 
Slideshare second messengers aj
Slideshare second messengers ajSlideshare second messengers aj
Slideshare second messengers aj
Anu Priya
 
Genome organization and gene expression and its regulation
Genome organization and gene expression and its regulationGenome organization and gene expression and its regulation
Genome organization and gene expression and its regulation
abhishek soni
 

Viewers also liked (20)

Sodium channel modulators
Sodium channel modulatorsSodium channel modulators
Sodium channel modulators
MOHANLAL CHOUDHARY
 
channelopathies
channelopathieschannelopathies
channelopathies
Pradip Katwal
 
Ion channels
Ion channelsIon channels
Ion channels
vinod karangiya
 
General Structure of Ion Channels
General Structure of Ion ChannelsGeneral Structure of Ion Channels
General Structure of Ion Channels
Satadru Dey
 
Potassium channel openers
Potassium channel openers Potassium channel openers
Potassium channel openers
Naser Tadvi
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
damarisb
 
The Resting Potential And The Action Potential
The  Resting  Potential And The  Action  PotentialThe  Resting  Potential And The  Action  Potential
The Resting Potential And The Action Potential
neurosciust
 
GPAT-SCORE CARD
GPAT-SCORE CARDGPAT-SCORE CARD
GPAT-SCORE CARD
MOHANLAL CHOUDHARY
 
Polonia
PoloniaPolonia
Polonia
secondag dicambio
 
Cellular electrophysiology
Cellular electrophysiologyCellular electrophysiology
Cellular electrophysiology
Manju Chhetri
 
A 3 d view of sodium channels
A 3 d view of sodium channelsA 3 d view of sodium channels
A 3 d view of sodium channels
Prosenjit Pal
 
Polonia
PoloniaPolonia
Polonia
ariannaalice
 
Action potential in a neuron part 3 voltage gated sodium channel
Action potential in a neuron part 3 voltage gated sodium channelAction potential in a neuron part 3 voltage gated sodium channel
Action potential in a neuron part 3 voltage gated sodium channel
Robert Anthony Ricketson
 
Membrane transport
Membrane transportMembrane transport
Membrane transport
Rawat DA Greatt
 
Clinical neurology epilepsy and seizures
Clinical neurology epilepsy and seizuresClinical neurology epilepsy and seizures
Clinical neurology epilepsy and seizures
Dr.mujahid Abdallah
 
Membrane transport
Membrane transportMembrane transport
Membrane transport
IB Screwed
 
Hodgkin-Huxley & the nonlinear dynamics of neuronal excitability
Hodgkin-Huxley & the nonlinear  dynamics of neuronal excitabilityHodgkin-Huxley & the nonlinear  dynamics of neuronal excitability
Hodgkin-Huxley & the nonlinear dynamics of neuronal excitability
SSA KPI
 
CML_Oral_Presentation
CML_Oral_PresentationCML_Oral_Presentation
CML_Oral_Presentation
Chris Locandro
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
Vijay Raj Yanamala
 
General Structure of Ion Channels
General Structure of Ion ChannelsGeneral Structure of Ion Channels
General Structure of Ion Channels
Satadru Dey
 
Potassium channel openers
Potassium channel openers Potassium channel openers
Potassium channel openers
Naser Tadvi
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
damarisb
 
The Resting Potential And The Action Potential
The  Resting  Potential And The  Action  PotentialThe  Resting  Potential And The  Action  Potential
The Resting Potential And The Action Potential
neurosciust
 
Cellular electrophysiology
Cellular electrophysiologyCellular electrophysiology
Cellular electrophysiology
Manju Chhetri
 
A 3 d view of sodium channels
A 3 d view of sodium channelsA 3 d view of sodium channels
A 3 d view of sodium channels
Prosenjit Pal
 
Action potential in a neuron part 3 voltage gated sodium channel
Action potential in a neuron part 3 voltage gated sodium channelAction potential in a neuron part 3 voltage gated sodium channel
Action potential in a neuron part 3 voltage gated sodium channel
Robert Anthony Ricketson
 
Clinical neurology epilepsy and seizures
Clinical neurology epilepsy and seizuresClinical neurology epilepsy and seizures
Clinical neurology epilepsy and seizures
Dr.mujahid Abdallah
 
Membrane transport
Membrane transportMembrane transport
Membrane transport
IB Screwed
 
Hodgkin-Huxley & the nonlinear dynamics of neuronal excitability
Hodgkin-Huxley & the nonlinear  dynamics of neuronal excitabilityHodgkin-Huxley & the nonlinear  dynamics of neuronal excitability
Hodgkin-Huxley & the nonlinear dynamics of neuronal excitability
SSA KPI
 

Similar to Na channel (20)

Sodium Ion Channel
Sodium Ion ChannelSodium Ion Channel
Sodium Ion Channel
nisha rani
 
Voltage gated sodium channels
Voltage gated sodium channelsVoltage gated sodium channels
Voltage gated sodium channels
NasimPourjalili
 
Voltage Operated channel, Receptor Operated channel, Second messenger Operate...
Voltage Operated channel, Receptor Operated channel, Second messenger Operate...Voltage Operated channel, Receptor Operated channel, Second messenger Operate...
Voltage Operated channel, Receptor Operated channel, Second messenger Operate...
Anantha Kumar
 
Sodium channel modulator
Sodium channel modulatorSodium channel modulator
Sodium channel modulator
DrReuben Syiem
 
2009 terni, università di medicina, i farmaci nel trattamento delle tachicar...
2009 terni, università di medicina, i farmaci nel trattamento delle tachicar...2009 terni, università di medicina, i farmaci nel trattamento delle tachicar...
2009 terni, università di medicina, i farmaci nel trattamento delle tachicar...
Centro Diagnostico Nardi
 
1-Cell signaling-2-Ligand gated ion channels.pdf
1-Cell signaling-2-Ligand gated ion channels.pdf1-Cell signaling-2-Ligand gated ion channels.pdf
1-Cell signaling-2-Ligand gated ion channels.pdf
chisomj225566
 
Unit 5 ion channel receptor
Unit  5 ion channel receptorUnit  5 ion channel receptor
Unit 5 ion channel receptor
PHARMA IQ EDUCATION
 
disorders relate to solute transport across biological membranes
disorders relate to solute transport across biological membranesdisorders relate to solute transport across biological membranes
disorders relate to solute transport across biological membranes
jayasreesarma611
 
anatomyphysiologyofneuromuscularjunctionmonitoring-110201023707-phpapp02 2.pdf
anatomyphysiologyofneuromuscularjunctionmonitoring-110201023707-phpapp02 2.pdfanatomyphysiologyofneuromuscularjunctionmonitoring-110201023707-phpapp02 2.pdf
anatomyphysiologyofneuromuscularjunctionmonitoring-110201023707-phpapp02 2.pdf
DrHardikDudhatra
 
Channels
ChannelsChannels
Channels
Kavya Jayakumar
 
Cell signaling part II-1.pdfdthtrsysrysru
Cell signaling part II-1.pdfdthtrsysrysruCell signaling part II-1.pdfdthtrsysrysru
Cell signaling part II-1.pdfdthtrsysrysru
SriRam071
 
Channelopathies pamela
Channelopathies pamelaChannelopathies pamela
Channelopathies pamela
Pamela Correia
 
DentalNeuro_04.ppt
DentalNeuro_04.pptDentalNeuro_04.ppt
DentalNeuro_04.ppt
Jane360787
 
Nervous system physiology 01
Nervous system physiology 01Nervous system physiology 01
Nervous system physiology 01
Saba Butt
 
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Pasteur_Tunis
 
Excitable Cells: Revision Notes
Excitable Cells: Revision NotesExcitable Cells: Revision Notes
Excitable Cells: Revision Notes
meducationdotnet
 
The neuromuscular junction disorders including myasthenia gravis
The neuromuscular junction disorders including myasthenia gravisThe neuromuscular junction disorders including myasthenia gravis
The neuromuscular junction disorders including myasthenia gravis
Sudhakar Marella
 
Anatomy & physiology of neuromuscular junction & monitoring
Anatomy & physiology of neuromuscular junction & monitoringAnatomy & physiology of neuromuscular junction & monitoring
Anatomy & physiology of neuromuscular junction & monitoring
havalprit
 
Structural Determinants of Drugs Acting on the Nav1.8 Channel
Structural Determinants of Drugs Acting on the Nav1.8 ChannelStructural Determinants of Drugs Acting on the Nav1.8 Channel
Structural Determinants of Drugs Acting on the Nav1.8 Channel
Shahnaz Yusaf
 
Mechanisms of action and use of blockers of sodium channels
Mechanisms of action and use of blockers of sodium channelsMechanisms of action and use of blockers of sodium channels
Mechanisms of action and use of blockers of sodium channels
SalemBabajide
 
Sodium Ion Channel
Sodium Ion ChannelSodium Ion Channel
Sodium Ion Channel
nisha rani
 
Voltage gated sodium channels
Voltage gated sodium channelsVoltage gated sodium channels
Voltage gated sodium channels
NasimPourjalili
 
Voltage Operated channel, Receptor Operated channel, Second messenger Operate...
Voltage Operated channel, Receptor Operated channel, Second messenger Operate...Voltage Operated channel, Receptor Operated channel, Second messenger Operate...
Voltage Operated channel, Receptor Operated channel, Second messenger Operate...
Anantha Kumar
 
Sodium channel modulator
Sodium channel modulatorSodium channel modulator
Sodium channel modulator
DrReuben Syiem
 
2009 terni, università di medicina, i farmaci nel trattamento delle tachicar...
2009 terni, università di medicina, i farmaci nel trattamento delle tachicar...2009 terni, università di medicina, i farmaci nel trattamento delle tachicar...
2009 terni, università di medicina, i farmaci nel trattamento delle tachicar...
Centro Diagnostico Nardi
 
1-Cell signaling-2-Ligand gated ion channels.pdf
1-Cell signaling-2-Ligand gated ion channels.pdf1-Cell signaling-2-Ligand gated ion channels.pdf
1-Cell signaling-2-Ligand gated ion channels.pdf
chisomj225566
 
disorders relate to solute transport across biological membranes
disorders relate to solute transport across biological membranesdisorders relate to solute transport across biological membranes
disorders relate to solute transport across biological membranes
jayasreesarma611
 
anatomyphysiologyofneuromuscularjunctionmonitoring-110201023707-phpapp02 2.pdf
anatomyphysiologyofneuromuscularjunctionmonitoring-110201023707-phpapp02 2.pdfanatomyphysiologyofneuromuscularjunctionmonitoring-110201023707-phpapp02 2.pdf
anatomyphysiologyofneuromuscularjunctionmonitoring-110201023707-phpapp02 2.pdf
DrHardikDudhatra
 
Cell signaling part II-1.pdfdthtrsysrysru
Cell signaling part II-1.pdfdthtrsysrysruCell signaling part II-1.pdfdthtrsysrysru
Cell signaling part II-1.pdfdthtrsysrysru
SriRam071
 
Channelopathies pamela
Channelopathies pamelaChannelopathies pamela
Channelopathies pamela
Pamela Correia
 
DentalNeuro_04.ppt
DentalNeuro_04.pptDentalNeuro_04.ppt
DentalNeuro_04.ppt
Jane360787
 
Nervous system physiology 01
Nervous system physiology 01Nervous system physiology 01
Nervous system physiology 01
Saba Butt
 
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Etude des canaux ioniques intérêts pour la physiopathologie et le traitement ...
Pasteur_Tunis
 
Excitable Cells: Revision Notes
Excitable Cells: Revision NotesExcitable Cells: Revision Notes
Excitable Cells: Revision Notes
meducationdotnet
 
The neuromuscular junction disorders including myasthenia gravis
The neuromuscular junction disorders including myasthenia gravisThe neuromuscular junction disorders including myasthenia gravis
The neuromuscular junction disorders including myasthenia gravis
Sudhakar Marella
 
Anatomy & physiology of neuromuscular junction & monitoring
Anatomy & physiology of neuromuscular junction & monitoringAnatomy & physiology of neuromuscular junction & monitoring
Anatomy & physiology of neuromuscular junction & monitoring
havalprit
 
Structural Determinants of Drugs Acting on the Nav1.8 Channel
Structural Determinants of Drugs Acting on the Nav1.8 ChannelStructural Determinants of Drugs Acting on the Nav1.8 Channel
Structural Determinants of Drugs Acting on the Nav1.8 Channel
Shahnaz Yusaf
 
Mechanisms of action and use of blockers of sodium channels
Mechanisms of action and use of blockers of sodium channelsMechanisms of action and use of blockers of sodium channels
Mechanisms of action and use of blockers of sodium channels
SalemBabajide
 

Recently uploaded (20)

History collection of a patient with renal disorder.pptx
History collection of a patient with renal disorder.pptxHistory collection of a patient with renal disorder.pptx
History collection of a patient with renal disorder.pptx
Rishika Rawat
 
SOPHE navigating digital complexity for health education in 21st centiry
SOPHE navigating digital complexity for health education in 21st centirySOPHE navigating digital complexity for health education in 21st centiry
SOPHE navigating digital complexity for health education in 21st centiry
Tina Purnat
 
Ethical Concerns in Regenerative Medicine and Tissue Engineering: A Course Le...
Ethical Concerns in Regenerative Medicine and Tissue Engineering: A Course Le...Ethical Concerns in Regenerative Medicine and Tissue Engineering: A Course Le...
Ethical Concerns in Regenerative Medicine and Tissue Engineering: A Course Le...
ajefferi
 
Luteal phase support in Assisted Reproducton.pdf
Luteal phase support in Assisted Reproducton.pdfLuteal phase support in Assisted Reproducton.pdf
Luteal phase support in Assisted Reproducton.pdf
Ahmed Mowafy
 
1140411-Prolonged_Dual_Antiplatelet_or_Antithrombotic_Therapy_An_Update.pdf
1140411-Prolonged_Dual_Antiplatelet_or_Antithrombotic_Therapy_An_Update.pdf1140411-Prolonged_Dual_Antiplatelet_or_Antithrombotic_Therapy_An_Update.pdf
1140411-Prolonged_Dual_Antiplatelet_or_Antithrombotic_Therapy_An_Update.pdf
Ks doctor
 
Breast Tumors and Breast cancer and prevention .pptx
Breast Tumors and Breast cancer and prevention .pptxBreast Tumors and Breast cancer and prevention .pptx
Breast Tumors and Breast cancer and prevention .pptx
Rishika Rawat
 
Fundus Camera MUCLecture_2024_4344921 (1).pptx
Fundus Camera MUCLecture_2024_4344921 (1).pptxFundus Camera MUCLecture_2024_4344921 (1).pptx
Fundus Camera MUCLecture_2024_4344921 (1).pptx
shelgohary
 
Grazi - Personalizing surgical strategy in HPB surgery.pptx
Grazi - Personalizing surgical strategy in HPB surgery.pptxGrazi - Personalizing surgical strategy in HPB surgery.pptx
Grazi - Personalizing surgical strategy in HPB surgery.pptx
Gian Luca Grazi
 
MIDFACIAL_DEGLOVING-SarayuShivani_U.pptx
MIDFACIAL_DEGLOVING-SarayuShivani_U.pptxMIDFACIAL_DEGLOVING-SarayuShivani_U.pptx
MIDFACIAL_DEGLOVING-SarayuShivani_U.pptx
Sarayu Shivani Udhayakumar
 
Short QT syndrome. Description, Evaluation, ECG changes.
Short QT syndrome. Description, Evaluation, ECG changes.Short QT syndrome. Description, Evaluation, ECG changes.
Short QT syndrome. Description, Evaluation, ECG changes.
SyedFaisalAhmed12
 
Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...
Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...
Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...
PRAVEEN RAJA S
 
Dental Avulsion & its Management
Dental Avulsion & its ManagementDental Avulsion & its Management
Dental Avulsion & its Management
Dr. Mukesh Kumar Dey
 
Iron, Hemoglobin and bilirubin Metabolism
Iron, Hemoglobin and bilirubin MetabolismIron, Hemoglobin and bilirubin Metabolism
Iron, Hemoglobin and bilirubin Metabolism
MedicoseAcademics
 
CHILDBIRTH POSITION DURING LABOR AND DELIVERYpptx
CHILDBIRTH POSITION DURING LABOR AND DELIVERYpptxCHILDBIRTH POSITION DURING LABOR AND DELIVERYpptx
CHILDBIRTH POSITION DURING LABOR AND DELIVERYpptx
daminipatel37
 
Chronic Obstructive Pulmonary Disease, Nursing
Chronic Obstructive Pulmonary Disease, NursingChronic Obstructive Pulmonary Disease, Nursing
Chronic Obstructive Pulmonary Disease, Nursing
Anurag Joseph
 
Silent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptx
Silent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptxSilent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptx
Silent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptx
zeelm1995
 
case presentation paronychia case presentation.pptx
case presentation paronychia case presentation.pptxcase presentation paronychia case presentation.pptx
case presentation paronychia case presentation.pptx
alshjrtnsybt
 
Coronary stents: A comprehensive overview of coronary stents
Coronary stents: A comprehensive overview of coronary stentsCoronary stents: A comprehensive overview of coronary stents
Coronary stents: A comprehensive overview of coronary stents
AhmedElBorae1
 
physical examination .pptx
physical examination               .pptxphysical examination               .pptx
physical examination .pptx
Kniranda Mayanglambam
 
HTD-9-2-PPH-XIII.pptxKJJIJKLMKO;K;,;;L,L,L,
HTD-9-2-PPH-XIII.pptxKJJIJKLMKO;K;,;;L,L,L,HTD-9-2-PPH-XIII.pptxKJJIJKLMKO;K;,;;L,L,L,
HTD-9-2-PPH-XIII.pptxKJJIJKLMKO;K;,;;L,L,L,
TeonaMacharashvili
 
History collection of a patient with renal disorder.pptx
History collection of a patient with renal disorder.pptxHistory collection of a patient with renal disorder.pptx
History collection of a patient with renal disorder.pptx
Rishika Rawat
 
SOPHE navigating digital complexity for health education in 21st centiry
SOPHE navigating digital complexity for health education in 21st centirySOPHE navigating digital complexity for health education in 21st centiry
SOPHE navigating digital complexity for health education in 21st centiry
Tina Purnat
 
Ethical Concerns in Regenerative Medicine and Tissue Engineering: A Course Le...
Ethical Concerns in Regenerative Medicine and Tissue Engineering: A Course Le...Ethical Concerns in Regenerative Medicine and Tissue Engineering: A Course Le...
Ethical Concerns in Regenerative Medicine and Tissue Engineering: A Course Le...
ajefferi
 
Luteal phase support in Assisted Reproducton.pdf
Luteal phase support in Assisted Reproducton.pdfLuteal phase support in Assisted Reproducton.pdf
Luteal phase support in Assisted Reproducton.pdf
Ahmed Mowafy
 
1140411-Prolonged_Dual_Antiplatelet_or_Antithrombotic_Therapy_An_Update.pdf
1140411-Prolonged_Dual_Antiplatelet_or_Antithrombotic_Therapy_An_Update.pdf1140411-Prolonged_Dual_Antiplatelet_or_Antithrombotic_Therapy_An_Update.pdf
1140411-Prolonged_Dual_Antiplatelet_or_Antithrombotic_Therapy_An_Update.pdf
Ks doctor
 
Breast Tumors and Breast cancer and prevention .pptx
Breast Tumors and Breast cancer and prevention .pptxBreast Tumors and Breast cancer and prevention .pptx
Breast Tumors and Breast cancer and prevention .pptx
Rishika Rawat
 
Fundus Camera MUCLecture_2024_4344921 (1).pptx
Fundus Camera MUCLecture_2024_4344921 (1).pptxFundus Camera MUCLecture_2024_4344921 (1).pptx
Fundus Camera MUCLecture_2024_4344921 (1).pptx
shelgohary
 
Grazi - Personalizing surgical strategy in HPB surgery.pptx
Grazi - Personalizing surgical strategy in HPB surgery.pptxGrazi - Personalizing surgical strategy in HPB surgery.pptx
Grazi - Personalizing surgical strategy in HPB surgery.pptx
Gian Luca Grazi
 
Short QT syndrome. Description, Evaluation, ECG changes.
Short QT syndrome. Description, Evaluation, ECG changes.Short QT syndrome. Description, Evaluation, ECG changes.
Short QT syndrome. Description, Evaluation, ECG changes.
SyedFaisalAhmed12
 
Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...
Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...
Isoquinoline alkaloid Berberine A beneficial molecule for reducing Diabetes m...
PRAVEEN RAJA S
 
Iron, Hemoglobin and bilirubin Metabolism
Iron, Hemoglobin and bilirubin MetabolismIron, Hemoglobin and bilirubin Metabolism
Iron, Hemoglobin and bilirubin Metabolism
MedicoseAcademics
 
CHILDBIRTH POSITION DURING LABOR AND DELIVERYpptx
CHILDBIRTH POSITION DURING LABOR AND DELIVERYpptxCHILDBIRTH POSITION DURING LABOR AND DELIVERYpptx
CHILDBIRTH POSITION DURING LABOR AND DELIVERYpptx
daminipatel37
 
Chronic Obstructive Pulmonary Disease, Nursing
Chronic Obstructive Pulmonary Disease, NursingChronic Obstructive Pulmonary Disease, Nursing
Chronic Obstructive Pulmonary Disease, Nursing
Anurag Joseph
 
Silent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptx
Silent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptxSilent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptx
Silent Signals_ Recognizing Early Markers in Hematologic Malignancies.pptx
zeelm1995
 
case presentation paronychia case presentation.pptx
case presentation paronychia case presentation.pptxcase presentation paronychia case presentation.pptx
case presentation paronychia case presentation.pptx
alshjrtnsybt
 
Coronary stents: A comprehensive overview of coronary stents
Coronary stents: A comprehensive overview of coronary stentsCoronary stents: A comprehensive overview of coronary stents
Coronary stents: A comprehensive overview of coronary stents
AhmedElBorae1
 
HTD-9-2-PPH-XIII.pptxKJJIJKLMKO;K;,;;L,L,L,
HTD-9-2-PPH-XIII.pptxKJJIJKLMKO;K;,;;L,L,L,HTD-9-2-PPH-XIII.pptxKJJIJKLMKO;K;,;;L,L,L,
HTD-9-2-PPH-XIII.pptxKJJIJKLMKO;K;,;;L,L,L,
TeonaMacharashvili
 

Na channel

  • 1. By – SARVESH MAURYA DR.L.H.HIRANANDANI COLLEGE OF PHARMACY.
  • 2.  MOLECULAR ARCHITECTURE OF ION CHANNELS • Ion channels are large and elaborate molecules. All consist of several (often four) domains, which are similar or identical to each other, organised either as an oligomeric array of separate subunits, or as one large protein. • Each subunit or domain contains a bundle of two to six membrane-spanning helices. Most ligand-gated channels have the basic structure, comprising a pentameric array of non-identical subunits, each consisting of four transmembrane helices. •The large extracellular N-terminal region contains the ligand-binding region
  • 3. Types Of Na+ Channels •Voltage gated – Changes in membrane polarity open the channel
  • 4. •Ligand gated (nicotinic acetylcholine receptor) – Ligand binding alters channel/receptor conformation and opens the pore •Mechanically gated (stretch receptor) – Physical torsion or deformation opens the channel pore
  • 5. Voltage-gated sodium channels: Introduction • Voltage-gated sodium channels are responsible for action potential initiation and propagation in excitable cells, including nerve, muscle, and neuroendocrine cell types. • They are also expressed at low levels in nonexcitable cells, where their physiological role is unclear. Sodium channels are the founding members of the ion channel superfamily in terms of their discovery as a protein and determination of their amino acid sequence. Sodium Channel Subunits • Sodium channels consist of a highly processed α subunit, which is approximately 260 kDa, associated with auxiliary β subunits Sodium channels in the adult central nervous system and heart contain β1 through β4 subunits, whereas sodium channels in adult skeletal muscle have only the β1 subunit . • The pore-forming α subunit is sufficient for functional expression, but the kinetics and voltage dependence of channel gating are modified by the β subunits, and these auxiliary subunits are involved in channel localization and interaction with cell adhesion molecules, extracellular matrix, and intracellular cytoskeleton.
  • 6. •The α subunits are organized in four homologous domains (I-IV), each of which contain six transmembrane α helices (S1-S6) and an additional pore loop located between the S5 and S6 segments (Fig. 1). The pore loops line the outer, narrow entry to the pore, whereas the S5 and S6 segments line the inner, wider exit from the pore. The S4 segments in each domain contain positively charged amino acid residues at every third position. •These residues serve as gating charges and move across the membrane to initiate channel activation in response to depolarization of the membrane. The short intracellular loop connecting homologous domains III and IV serves as the inactivation gate, folding into the channel structure and blocking the pore from the inside during sustained depolarization of the membrane. FIG. 1. Transmembrane organization of sodium channel subunits.
  • 7. •The primary structures of the subunits of the voltage-gated ion channels are illustrated as transmembrane-folding diagrams. Cylinders represent probable α-helical segments. Bold lines represent the polypeptide chains of each subunit, with length approximately proportional to the number of amino acid residues in the brain sodium channel subtypes. •The extracellular domains of the β1 and β2 subunits are shown as immunoglobulin-like folds. ψ, sites of probable N-linked glycosylation; P, sites of demonstrated protein phosphorylation by protein kinase A (circles) and protein kinase C (diamonds); shaded, pore-lining S5-P-S6 segments; white circles, the outer (EEDD) and inner (DEKA) rings of amino residues that form the ion selectivity filter and tetrodotoxin binding site; ++, S4 voltage sensors; h in shaded circle, inactivation particle in the inactivation gate loop; open shaded circles, sites implicated in forming the inactivation gate receptor. •Sites of binding of α- and β-scorpion toxins and a site of interaction between α and β1 subunits are also shown.
  • 8. Sodium Channel Classification and Nomenclature  In this nomenclature system, the name of an individual channel consists of the chemical symbol of the principal permeating ion (Na) with the principal physiological regulator (voltage) indicated as a subscript (NaV).  The number following the subscript indicates the gene subfamily (currently only NaV1), and the number following the full point identifies the specific channel isoform (e.g., NaV1.1). This last number has been assigned according to the approximate order in which each gene was identified. Splice variants of each family member are identified by lowercase letters following the numbers (e.g., NaV1.1a).
  • 9. Genetic mutations in sodium channel genes give rise to channelopathies and clinical disease Channel nomenclature Gene Chromosomal location (human) Tetrodotoxin sensitivity Major tissue expression Effect of mutation Nav1.1 SCN1A 2q24 CNS, PNS Epilepsy Nav1.2 SCN2A 2q23–24 CNS, PNS Epilepsy Nav1.3 SCN3A 2q24 CNS, PNS None reported Nav1.4 SCN4A 17q23–25 Skeletal muscle Myotonia, periodic paralysis Nav1.5 SCN5A 3p21 Heart Long QT, Brugada syndrome, progressive familial heart block Nav1.6 SCN8A 12q13 CNS, PNS Cerebellar atrophy Nav1.7 SCN9A 2q24 PNS (SNS and PAs) Increased and decreased pain sensitivity Voltage-gated sodium channel nomenclature, chromosomal location and tissue distribution
  • 10. Sodium Channels - Function Can be in different functional states (3) A resting state • when it can respond to a depolarizing voltage changes Activated • when it allows flow of Na+ ions through the Inactivated • when subjected to a “suprathreshold” potential, the channel will not open
  • 11. Na + Channel Blockers/Pharmacological Agents • Tetrodotoxin (TTX)(blocks voltage gated sodium channel) • Amioderone (blocks cardiac channel) • Lidocaine (blocks voltage sodium channel in neuronal cell membrane) • Procainamide • Mexilitine • Ketamine
  • 12. Tetrodoxin •Tetrodotoxin is the poison that is produced by the puffer fish and a number of other animals. It is a virulent poison, the LD50 for the mouse is 10 nanograms. • It acts by blocking the conduction of nerve impulses along nerve fibers and axons. The victim eventually dies from respiratory paralysis. Saxitoxin, a natural product from dinoflagellates, acts in a similar way and is also a potent nerve poison."
  • 13. If tetrodotoxin is such a powerful toxin why does it not poison the host? This is a common question in virtually all cases where a toxin is present. The sodium ion channel in the host must be different than that of the victim. It must not be susceptible to the toxin.
  • 14. It has been demonstrated for one of the pufferfish that the protein of the sodium ion channel has undergone a mutation that changes the amino acid sequence making the channel insensitive to tetrodotoxin. The spontaneous mutation that caused this structural change is beneficial to the pufferfish because it allowed it to incorporate the symbiotic bacteria and utilize the toxin it produces to its best advantage, A single point mutation in the amino acid sequence of the sodium-ion channel in this species renders it immune from being bound and blockaded by TTX.
  • 15. Side effects occur while taking Amiodarone Dizziness Cough trembling or shaking of the hands lightheadedness, or fainting, Dizziness Common side efects unusual and uncontrolled movements of the body shortnes s of breath Cough, fever (slight) numbness or tingling in the fingers or toes
  • 16. Blue-gray coloring of the skin on the face, neck, and arms Less common side effects blurred vision or blue-green halos seen around objects fast or irregular heartbeat dry, puffy skin dry eyes
  • 17. •REFERENCES •William A. Catterall, Alan L. Goldin, Stephen G. Waxman. Voltage-gated sodium channels, introductory chapter. •Adapted from the original article in Pharmacological Reviews